Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Ulf Dettmer, Ph.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01NS099328 (DETTMER, ULF) Aug 1, 2017 - May 31, 2022
    NIH/NINDS
    Stabilizing native ?-synuclein homeostasis to prevent insoluble ?-synuclein aggregates
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nuber S, Nam AY, Rajsombath MM, Cirka H, Hronowski X, Wang J, Hodgetts K, Kalinichenko LS, Müller CP, Lambrecht V, Winkler J, Weihofen A, Imberdis T, Dettmer U, Fanning S, Selkoe DJ. A stearoyl-CoA desaturase inhibitor prevents multiple Parkinson's disease-phenotypes in a-synuclein mice. Ann Neurol. 2020 Sep 29. PMID: 32996158.
    Citations:    
  2. Terry-Kantor E, Tripathi A, Imberdis T, LaVoie ZM, Ho GPH, Selkoe D, Fanning S, Ramalingam N, Dettmer U. Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor. Int J Mol Sci. 2020 Jul 22; 21(15). PMID: 32707907.
    Citations:    
  3. Fanning S, Selkoe D, Dettmer U. Vesicle trafficking and lipid metabolism in synucleinopathy. Acta Neuropathol. 2020 Jun 30. PMID: 32607605.
    Citations:    
  4. Fanning S, Selkoe D, Dettmer U. Parkinson's disease: proteinopathy or lipidopathy? NPJ Parkinsons Dis. 2020; 6:3. PMID: 31909184.
    Citations:    
  5. Kayed R, Dettmer U, Lesné SE. Soluble endogenous oligomeric a-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk. J Parkinsons Dis. 2020; 10(3):791-818. PMID: 32508330.
    Citations:    
  6. Imberdis T, Negri J, Ramalingam N, Terry-Kantor E, Ho GPH, Fanning S, Stirtz G, Kim TE, Levy OA, Young-Pearse TL, Selkoe D, Dettmer U. Cell models of lipid-rich a-synuclein aggregation validate known modifiers of a-synuclein biology and identify stearoyl-CoA desaturase. Proc Natl Acad Sci U S A. 2019 10 08; 116(41):20760-20769. PMID: 31548371.
    Citations:    
  7. Yeboah F, Kim TE, Bill A, Dettmer U. Dynamic behaviors of a-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration. Neurobiol Dis. 2019 12; 132:104543. PMID: 31351173.
    Citations:    
  8. Imberdis T, Fanning S, Newman A, Ramalingam N, Dettmer U. Studying a-Synuclein Conformation by Intact-Cell Cross-Linking. Methods Mol Biol. 2019; 1948:77-91. PMID: 30771172.
    Citations:    
  9. Fanning S, Haque A, Imberdis T, Baru V, Barrasa MI, Nuber S, Termine D, Ramalingam N, Ho GPH, Noble T, Sandoe J, Lou Y, Landgraf D, Freyzon Y, Newby G, Soldner F, Terry-Kantor E, Kim TE, Hofbauer HF, Becuwe M, Jaenisch R, Pincus D, Clish CB, Walther TC, Farese RV, Srinivasan S, Welte MA, Kohlwein SD, Dettmer U, Lindquist S, Selkoe D. Lipidomic Analysis of a-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Mol Cell. 2019 03 07; 73(5):1001-1014.e8. PMID: 30527540.
    Citations:    Fields:    
  10. Nuber S, Rajsombath M, Minakaki G, Winkler J, Müller CP, Ericsson M, Caldarone B, Dettmer U, Selkoe DJ. Abrogating Native a-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease. Neuron. 2018 10 10; 100(1):75-90.e5. PMID: 30308173.
    Citations:    Fields:    
  11. Dettmer U. Rationally Designed Variants of a-Synuclein Illuminate Its in vivo Structural Properties in Health and Disease. Front Neurosci. 2018; 12:623. PMID: 30319334.
    Citations:    
  12. Dettmer U, Ramalingam N, von Saucken VE, Kim TE, Newman AJ, Terry-Kantor E, Nuber S, Ericsson M, Fanning S, Bartels T, Lindquist S, Levy OA, Selkoe D. Loss of native a-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells. Hum Mol Genet. 2017 09 15; 26(18):3466-3481. PMID: 28911198.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  13. Collier TJ, Srivastava KR, Justman C, Grammatopoulous T, Hutter-Paier B, Prokesch M, Havas D, Rochet JC, Liu F, Jock K, de Oliveira P, Stirtz GL, Dettmer U, Sortwell CE, Feany MB, Lansbury P, Lapidus L, Paumier KL. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiol Dis. 2017 Oct; 106:191-204. PMID: 28711409.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  14. Dettmer U, Selkoe D, Bartels T. New insights into cellular a-synuclein homeostasis in health and disease. Curr Opin Neurobiol. 2016 Feb; 36:15-22. PMID: 26282834.
    Citations: 24     Fields:    Translation:HumansCells
  15. Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, von Saucken VE, Sanderson JB, Jaenisch R, Bartels T, Selkoe D. Corrigendum: Parkinson-causing a-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015 Jul 30; 6:8008. PMID: 26224447.
    Citations: 2     Fields:    
  16. Dettmer U, Newman AJ, von Saucken VE, Bartels T, Selkoe D. KTKEGV repeat motifs are key mediators of normal a-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity. Proc Natl Acad Sci U S A. 2015 Aug 04; 112(31):9596-601. PMID: 26153422.
    Citations: 25     Fields:    Translation:HumansAnimalsCells
  17. Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, von Saucken VE, Sanderson JB, Jaenisch R, Bartels T, Selkoe D. Parkinson-causing a-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015 Jun 16; 6:7314. PMID: 26076669.
    Citations: 55     Fields:    Translation:HumansAnimalsCells
  18. Dettmer U, Bartels T. ExPLAining early synucleinopathies. Brain. 2015 Jun; 138(Pt 6):1449-51. PMID: 26013805.
    Citations:    Fields:    Translation:Humans
  19. Luth ES, Bartels T, Dettmer U, Kim NC, Selkoe DJ. Purification of a-synuclein from human brain reveals an instability of endogenous multimers as the protein approaches purity. Biochemistry. 2015 Jan 20; 54(2):279-92. PMID: 25490121.
    Citations: 10     Fields:    Translation:HumansCells
  20. Newman AJ, Selkoe D, Dettmer U. A new method for quantitative immunoblotting of endogenous a-synuclein. PLoS One. 2013; 8(11):e81314. PMID: 24278419.
    Citations: 12     Fields:    Translation:HumansCells
  21. Selkoe D, Dettmer U, Luth E, Kim N, Newman A, Bartels T. Defining the native state of a-synuclein. Neurodegener Dis. 2014; 13(2-3):114-7. PMID: 24192542.
    Citations: 9     Fields:    Translation:HumansAnimals
  22. Dettmer U, Newman AJ, Luth ES, Bartels T, Selkoe D. In vivo cross-linking reveals principally oligomeric forms of a-synuclein and ß-synuclein in neurons and non-neural cells. J Biol Chem. 2013 Mar 01; 288(9):6371-85. PMID: 23319586.
    Citations: 57     Fields:    Translation:HumansAnimalsCells
  23. Dettmer U, Kuhn PH, Abou-Ajram C, Lichtenthaler SF, Krüger M, Kremmer E, Haass C, Haffner C. Transmembrane protein 147 (TMEM147) is a novel component of the Nicalin-NOMO protein complex. J Biol Chem. 2010 Aug 20; 285(34):26174-81. PMID: 20538592.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  24. Haffner C, Dettmer U, Weiler T, Haass C. The Nicastrin-like protein Nicalin regulates assembly and stability of the Nicalin-nodal modulator (NOMO) membrane protein complex. J Biol Chem. 2007 Apr 06; 282(14):10632-8. PMID: 17261586.
    Citations: 5     Fields:    Translation:HumansCells
  25. Chelius HH, Böhme K, Dettmer U. [Effect of hyperbilirubinemia on the physical and mental development of the diseased newborn infant]. Geburtshilfe Frauenheilkd. 1971 Sep; 31(9):823-32. PMID: 5098810.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dettmer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (128)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.